Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

OPKO Health And Entera Bio Enter Collaboration Agreement To Advance Oral GLP-1/Glucagon Tablet Candidate Into Clinic For Obesity And Metabolic Disorders; OPKO And Entera Will Hold 60% And 40% Pro-Rata Ownership Interests, Respectively; In Connection With Agreement, OPKO Purchased 3.685M Shares Of Entera At $2.17/Share

Author: Benzinga Newsdesk | March 17, 2025 08:02am

Posted In: ENTX OPK